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PAPER
Medial temporal lobe atrophy predicts Alzheimer’s
disease in patients with minor cognitive impairment
P J Visser, F R J Verhey, P A M Hofman, P Scheltens, J Jolles
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Objectives: To investigate whether medial temporal lobe atrophy predicted outcome in patients with
minor cognitive impairment and whether assessment of the medial temporal lobe could increase the
predictive accuracy of age and delayed recall for outcome. Quantitative and qualitative methods of
assessing the medial temporal lobe were also compared.
Methods: Patients with minor cognitive impairment older than 50 years (n=31) were selected from a
memory clinic and were followed up for on average 1.9 years. The medial temporal lobe was assessed
in three different ways: volumetry of the hippocampus, volumetry of the parahippocampal gyrus, and
qualitative rating of medial temporal lobe atrophy (MTA). Outcome measures were Alzheimer type
dementia or cognitive decline at follow up. Delayed recall was tested with a verbal learning test.
Results: Ten patients had experienced cognitive decline at follow up, of whom seven had probable
Alzheimer type dementia. All medial temporal lobe measurements were associated with cognitive
decline at follow up (p trend analysis between 0.001 (hippocampus) and 0.05 (parahippocampal
gyrus)). Only the hippocampal volume and MTA score were associated with Alzheimer type dementia
at follow up (p trend analysis respectively 0.003 and 0.01). All medial temporal lobe measurements
increased the predictive accuracy of age and the delayed recall score for cognitive decline (p increase
in predictive accuracy varied between <0.001 (hippocampus) and 0.02 (parahippocampal gyrus and
MTA score)) and the hippocampal volume and the MTA score increased the predictive accuracy of age
and the delayed recall score for Alzheimer type dementia (p= 0.02).
Conclusions: The ability to detect patients at high risk for Alzheimer type dementia among those with
minor cognitive impairment increases when data on age and memory function are combined with
measures of medial temporal lobe atrophy. Volumetry of the hippocampus is preferred, but qualitative
rating of medial temporal lobe atrophy is a good alternative.
Many patients who are investigated for cognitiveimpairment are not demented at the time of theexamination but some of them may develop Alzhe-
imer type dementia over several years. It is difficult to identify
these patients. It is important to select them because they may
benefit from drugs that have been shown to improve cognition
in patients with probable Alzheimer’s disease, or drugs that
may slow the progression of the disease.1 In addition, the
caregivers of these patients may benefit from counselling on
how to handle the cognitive impairment of their partners. One
of the best predictors of Alzheimer type dementia in patients
with minor cognitive impairment is memory function,2–4 but
the sensitivity of memory functioning for predicting Alzhe-
imer type dementia was less than 80% in most studies.2–4 In
addition, not all patients with memory impairment develop
Alzheimer type dementia and the memory impairment may
be reversible.5 Several studies have indicated that atrophy of
the medial temporal lobe is predictive of Alzheimer type
dementia in non-demented patients6–11 and that measures of
medial temporal lobe atrophy can improve the predictive
accuracy of memory function for Alzheimer type dementia6 10
or can predict the dementia independently from memory
function.11 Because only two of these studies were performed
in a clinical setting, it remains uncertain whether the medial
temporal lobe should be evaluated as part of the diagnostic
investigation of non-demented patients with mild cognitive
impairment. Moreover, as there are different methods of
assessing themedial temporal lobe, it is unclear whichmethod
has the best predictive accuracy: volumetry of the
hippocampus,9 volumetry of the parahippocampal gyrus,10 or
qualitative assessment of the medial temporal lobe.6 10
The aim of the present longitudinal study was to investigate
whether medial temporal lobe atrophy predicted outcome in
elderly patients with minor cognitive impairment and
whether assessment of the medial temporal lobe could
increase the predictive accuracy of age and delayed recall for
clinical outcome. We compared three different methods of
assessing the medial temporal lobe: volumetry of the hippoc-
ampus, volumetry of the parahippocampal gyrus, and qualita-
tive scoring of medial temporal lobe atrophy (MTA score).
Outcomewas defined as Alzheimer type dementia at follow up
or cognitive decline at follow up. The second outcomemeasure
not only included patients with Alzheimer type dementia at
follow up, but also patients with severe cognitive decline
without dementia at follow up.
METHODS
Patients
Patients with minor cognitive impairment were selected from
the Maastricht Memory Clinic, a university affiliated out-
patient clinic for patients with cognitive impairments.12
Patients were referred to the clinic by a general practitioner, a
neurologist, or a psychiatrist. Inclusion criteria were a score on
the global deterioration scale (GDS)13 of 2 or 3. Exclusion cri-
teria were age below 50 years, a baseline diagnosis of demen-
tia according to the DSM-IV criteria,14 sensory impairment,
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Abbreviations: MTA, medial temporal lobe atrophy; AD, Alzheimer
type dementia; GDS, global deterioration scale; HDRS, Hamilton
depression rating scale; MMSE, mini mental state examination; AVLT,
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psychosis, panic disorder, bipolar disorder, a score on the
Hamilton depression rating scale-17 items (HDRS)15 higher
than 22,16 or cognitive problems in relation to cerebrovascular
events, neurodegenerative diseases (for example, Parkinson’s
disease or Huntington’s disease), brain neoplasm, head
trauma, drug intoxication, alcohol misuse, hypothyroid or
hyperthyroid function, or vitamin deficiency. Thirty one
patients were included in the study. Some of these patients
had vascular risk factors or vascular disorders—that is, hyper-
tension (diastolic blood pressure >95, systolic blood pressure
>170 on a single measurement, or treatment for hyper-
tension) (n=8), total cholesterol serum concentrations >6.0
mmol/l (n=5), smoking (n=6), angina pectoris (n=1),
transient ischaemic attack (n=2), and lacunar infarction on
MRI (n=2). The vascular disorders were thought not to be
related to the cognitive impairment because there was no
relation between the vascular event and the onset of cognitive
impairment, nor was there a sudden onset of cognitive
impairment. After the study was explained to them, patients
gave their written informed consent.
Baseline assessment and clinical diagnosis
At baseline patients underwent a standardised assessment
which included a detailed history provided by the patient and
a relevant other person, a psychiatric, neurological, and physi-
cal examination, appropriate laboratory tests, and a neuro-
psychological assessment (see below) as described
elsewhere.12 In addition, the mini mental state examination
(MMSE),17 as a measure of global cognitive impairment, the
GDS,13 which is a scale for staging levels of cognitive
impairment, the Blessed dementia rating scale part I,18 as a
measure of functional impairment, and the HDRS,15 were
administered. Psychiatric diagnoses were made according to
DSM-IV criteria.14 The diagnosis of Alzheimer type dementia
was made according to the NINCDS-ADRDA criteria.19 No
patient received antidementia drugs.
Follow up assessment
The patients were invited for a follow up assessment between
1 and 3 years after the first assessment. The average follow up
period was 1.9 years (SD 0.7). The follow up assessment con-
sisted of a standardised questionnaire about medical history
and cognitive complaints, the MMSE, the GDS, the HDRS, and
a neuropsychological assessment (see below). The diagnosis at
follow up was made by an experienced neuropsychiatrist who
was unaware of the results of the baseline assessment includ-
ing the MRI data. If the patient refused to come for the follow
up assessment, a telephone interview was conducted which
included a standardised questionnaire about medical history
and cognitive complaints (n=1). No neuropsychological test-
ing was done at follow up in seven patients because of refusal
(n=5), severe cognitive impairment (n=1), or severe illness
(n=1).
The diagnosis of cognitive decline at follow up was made
when patients had Alzheimer type dementia or when severe
cognitive decline without dementia was present at follow up.
Decline in non-demented patients was defined as a negative
change of four points or more on theMMSE20 or decline on the
delayed recall task such that both a decline >1 SD on the task
was present and the follow up score was below the 10th per-
centile. The last restriction was taken to exclude patients with
regression to the mean. When only the MMSE or the delayed
recall score was available at follow up (n=2), the patient was
classified according to that score only.
Neuropsychological methodology
The neuropsychological assessment consisted of a series of
standard clinical tests,12 21 including the auditory verbal learn-
ing test (AVLT) (a test that assesses immediate and delayed
recall of a list of 15 unrelated words),22 23 the Stroop colour
word test (SCWT) (a test that assesses simple (card 1) and
complex cognitive speed (card 3)),24 verbal fluency (the ability
to name as many professions/trades as possible within 1
minute), and intelligence.25 Delayed recall performance of the
AVLT was selected because several studies have indicated that
this is a strong neuropsychological predictor of Alzheimer type
dementia.2 3 Delayed recall performance was not tested at
baseline in two patients because they refused to do the test.
Because the cognitive scores correlated with age, sex, and
education, we corrected the scores for these variables. Intelli-
gence was corrected according to published age norms and
expressed as an intelligence quotient (IQ).25 The correction of
the other cognitive scores was based on a reference population
of 1070 cognitively normal patients older than 50 years who
had been randomly selected from a registry of general practi-
tioners as described in detail elsewhere.26 27 On the basis of the
reference population, an expected score for a given age, sex,
and level of education was calculated.5 16 This score was
subtracted from the observed score and the residue was
divided by the SD of the residue in the reference population to
give a z score.5 The sign of the z scores of the SCWT cards 1 and
3 was inverted such that a z score below zero indicated below
average performance. We did not correct the MMSE score, in
order to facilitate comparisons with other studies. In addition,
the analyses with uncorrected MMSE scores yielded similar
results as the analyses with corrected MMSE scores.
MRI methodology
A three dimensional volumetric scan (T1 weighted, fast field
echo, TR 24 ms, TE 7 ms, flipangle 30°, number of averages=2,
FOV 230 mm, resolution 256×154) and an inversion recovery
scan (TR 2107 ms, TE 18 ms, turbofactor=3, flipangle 90°,
number of averages=2, FOV 230 mm, resolution 256×177)
were performed on a 1.5 Tesla scanner (Gyroscan ACS-II,
Philips). The slice thickness of the three dimensional
volumetric scan was 1.5 mm and the scan axis was coronal,
perpendicular to the intercommissural line. The slice thick-
ness of inversion recovery scan was 3 mm and the scan axis
was coronal, perpendicular to the long axis of the hippocam-
pus. The hippocampus, the parahippocampal gyrus, and the
intracranial area were measured on the three dimensional
volume scan and the MTA score was determined from the
inversion recovery scan.
Methodology of brain measurements
Data were transferred to a SUNworkstation and the regions of
interest were measured with ShowImage (developed at the
Department of Clinical Physics and Informatics, VrijeUniver-
siteit, Amsterdam, The Netherlands).28 The MR scan of one
patient was not available for volumetry and in this patient
only the qualitative rating was performed. The brain
structures were manually traced with a mouse driven cursor.
The volumes of the left side and right side were added. The
volume of the brain structure was calculated by multiplying
the surface area of each region of interest by the slice
thickness and summing the volumes of all slices on which the
structure was measured. Measurements were done with
reference to an anatomical atlas.29 The hippocampus and
parahippocampal gyrus were measured by one rater and the
intracranial area was measured by another rater. All raters
were blinded to all clinical information.
Volumetry of the hippocampus, parahippocampal gyrus,
and intracranial area
The hippocampus was measured on the slice on which both
the semiannular sulcus and a notch between the amygdala
and the hippocampus in the medial wall of the lateral ventri-
cle were visible,29 and then on every second slice. The last slice
was that before the slice on which the crura of the fornices
were visible. On average 10 slices on each side were measured
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(range 8–13). The volume of the parahippocampal gyrus was
measured on the same slices, except for the last slice in order
not to include the isthmus of the cingulate gyrus. On average
nine slices on each side were measured (range 7–12). The
intracranial area was measured in a rostrocaudal direction on
three slices: on the first slice on which the third ventricle
appeared, on the slice on which the mamillary bodies had the
largest volume, and on the last slice on which the third ventri-
cle was visible. The anatomical boundaries of the hippocam-
pus, parahippocampal gyrus, and intracranial area have been
described in detail elsewhere.30 Ten scans were remeasured to
assess the intraobserver variability. The intraclass correlation
coefficient between the first and second measurement was
0.95 for the hippocampus, 0.92 for the parahippocampal
gyrus, and 0.99 for the intracranial area.
The volumes of the hippocampus and parahippocampal
gyrus were corrected for age, sex, intracranial area, and
number of slices.30 We corrected for the number of slices on
which the volume of the hippocampus or parahippocampal
gyrus were measured in order to reduce the variance because
the number of slices correlated with the total volume of the
hippocampus and parahippocampal gyrus but the number of
slices did not depend on atrophy of these structures.30 The cor-
rection for age, sex, intracranial area, and number of slices was
based on a population of 60 healthy patients aged between 21
and 82 years (average age 56 years (SD 15.9)).31 Regression
analysis was performed with the brain structure as dependent
variable and intracranial area, age, number of slices, sex, and
the interaction term age by sex (because of reported
differences in aging between males and females) as independ-
ent variables.30 Variables and interaction terms that were
significant at the p=0.05 level were included in the final
model. These variables were age, sex, intracranial area, and
number of slices in the model with hippocampal volume as
dependent variable and age, intracranial area, and number of
slices in the model with parahippocampal gyrus volume as
dependent variable. Because age was included in both
regression models the data of the reference population could
be used for the correction of brain volumes in the study popu-
lation even though the age range in the reference population
was not the same as that in the study population.31 On the
basis of the regression model we calculated z scores in the
same way as we did for the delayed recall. We classified the
brain volumes on the basis of the z score in tertiles. A z score
above 0.44 corresponds to a brain volume in the highest tertile
of the reference population, a z score between 0.44 and −0.44
corresponds to a brain volume in the middle tertile of the ref-
erence population, a z score below −0.44 corresponds to a brain
volume in the lowest tertile of the reference population.
MTA score
TheMTA score is based on a visual estimation of the volume of
the medial temporal lobe, including the hippocampus proper,
dentate gyrus, subiculum, and parahippocampal gyrus, and
the volume of the surrounding CSF spaces, in particular the
temporal horn of the lateral ventricle and the choroid fissure,
on both sides.32 33 The MTA score ranges from 0 (no atrophy) to
4 (severe atrophy). The MTA was scored by a neurologist who
was blinded to all clinical information. The intrarater reliabil-
ity of this rater was substantial (κ=0.70).34 The left and right
MTA scores were averaged and corrected for age and sex using
multiple linear regression on the basis of the same reference
population that was used for correcting the hippocampal and
parahippocampal gyrus volume. A z score was calculated as
described above. The sign of the z scores was inverted such
that a z score below zero indicated more than average atrophy.
We classified the MTA rating on the basis of the z score in ter-
tiles in the same way as we did for the hippocampus and
parahippocampal gyrus.
Statistics
The data were analyzed using SPSS for the Macintosh 4.0
(SPSS Inc, Chigaco, IL, USA). Trend analysis was used to
investigate the relation between the tertile scores of hippoc-
ampal volume, parahippocampal gyrus volume, or MTA score
and change in cognitive function and cognitive outcome. In
the trend analyses the tertile scores were considered a
continuous variable in a multiple linear regression model.
Intraclass correlation coefficients were calculated to assess the
intraobserver and interobserver variability.35 Logistic
regression was used to evaluate the predictive value of age
(50–60 years, 60–70 years, and >70 years), delayed recall, and
the z scores of the hippocampal volume or parahippocampal
gyrus volume or MTA score for clinical outcome (Alzheimer
type dementia v no Alzheimer type dementia, and the absence
or presence of cognitive decline at follow up). Age was used as
a predictor because it is a risk factor for Alzheimer type
dementia that is independent of age corrected brain volumes
or age corrected memory scores.5 11 Age and delayed recall
were added in the first two steps and the brain volume or MTA
score in the third step. To assess whether the goodness of fit
improved after each step, the decrease in deviance (or −2 log
likelihood) was tested. All tests were two tailed, and the
significance level was set at 0.05.
RESULTS
Baseline characteristics of the study population are listed in
table 1. Information on the presence or absence of Alzheimer
type dementia was available in 30 patients (97%). Seven
patients (22% of the patients with known outcome) were
demented and had probable Alzheimer type dementia at
follow up. Of the patients with no dementia at follow up
(n=23), three had cognitive decline at follow up (two patients
with a decline on the MMSE >4, and one patient with a
decline on the delayed recall >1 SD), 17 patients had no cog-
nitive decline, and three patients had no cognitive scores at
follow up. The patients with Alzheimer type dementia at
follow up and the non-demented patients with cognitive
decline at follow up will be referred to as the cognitive decline
group (n=10).
There was a statistically significant association between the
volume of the hippocampus and theMTA score at baseline and
Table 1 Patient characteristics
No 31
Age (y) 64.9 (9.5)
Sex ratio 18M:13F
Education (y)* 10.7 (3.2)
MMSE score 27.7 (1.8)
GDS score:
2 17
3 14
BDRS score 1.9 (1.9)
HDRS score 9.8 (6.5)
Immediate recall (z score) 0.02 (1.3)
Delayed recall (raw score) 6.1 (3.0)
Delayed recall (z score) −0.91 (0.84)
SCWT: card 1 (z score) −1.0 (1.5)
SCWT: card 3 (z score) −1.84 (1.3)
Verbal fluency (z score) −0.80 (1.0)
IQ 112.3 (12.5)
Hippocampus (z score) −0.23 (1.1)
Parahippocampal gyrus (z score) 0.10 (1.1)
MTA score (uncorrected, average of left and rigth side) 1.1 (1.1)
MTA score (z score) −0.35 (1.4)
Values are means (SD).
*Years spent in primary, secondary and higher level education.
MMSE, mini mental state examination; GDS, global deterioration
scale; HDRS, Hamilton depression rating scale; BDRS, Blessed
dementia rating scale; SCWT, Stroop colour word test, IQ,
intelligence quotient; MTA, medial temporal lobe atrophy.
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decline on the MMSE, the diagnosis of Alzheimer type
dementia, and the diagnosis of cognitive decline at follow up.
The volume of the parahippocampal gyrus was significantly
associated with decline on the MMSE and cognitive decline at
follow up, and tended to be associated with change in delayed
recall performance at follow up (table 2). These associations
remained similar after adjustments for duration of follow up.
The association between medial temporal lobe atrophy and
change of cognitive scores remained the same after correction
for the baseline cognitive scores. None of the measures of
medial temporal lobe atrophy was associated with age or cog-
nitive scores at baseline except for the MTA score that was
associated with age at baseline.
In the logistic regression analyses three patients were
excluded because of missing data: two patients had no delayed
recall score at baseline and in one patient medial temporal
lobe atrophy was only assessed with the qualitative rating
scale and not with volumetry. The first set of logistic
regression analyses was performed with Alzheimer type
dementia at follow up as dependent variable and included
data for six patients with Alzheimer type dementia at follow
up and 21 non-demented patients. After age and the delayed
recall score were entered in the first two steps, the hippocam-
pus volume and the MTA score improved the model (table 3).
In the second set of logistic regression analyses, the dependent
variable was cognitive decline at follow up and included data
for nine patients with cognitive decline at follow up and 15
patients without cognitive decline. After age and the delayed
recall score were entered in the first two steps, the volumes of
the hippocampus and the parahippocampal gyrus, and the
MTA score all improved the model (table 3). The decrease in
deviance was largest for the hippocampal volume, indicating
that this variable increased the predictive accuracy the most.
DISCUSSION
The main findings of this prospective study of patients with
minor cognitive impairment in a clinical setting were that
measures of medial temporal atrophy predicted outcome at
follow up and improved the predictive accuracy of age and
delayed recall performance for outcome. The hippocampal
volume was a better predictor of outcome than the MTA score,
and the MTA score was a better predictor than the
parahippocampal gyrus volume.
Table 2 Baseline and follow up data for parahippocampal volume, hippocampal
gyrus volume, and MTA score
Hippocampus volume at baseline*
p Value trend
analysisHighest tertile Middle tertile Lowest tertile
(A) Baseline and follow up data according to hippocampal volume at baseline:
Number 9 9 12
Baseline data
Age (y) 60.6 (8.6) 65.9 (8.4) 66.9 (10.9) 0.15
MMSE score 27.8 (1.7) 27.9 (1.7) 27.3 (2.1) 0.50
Delayed recall (z score) −1.15 (0.84) −0.42 (0.84)† −1.1 (0.80)† 0.94
Follow up data
Change MMSE 0.0 (2.2)§ −0.78 (1.7) −4.7 (4.4)§ 0.002
Change delayed recall 0.73 (1.2)§ −0.33 (1.2)† −0.29 (1.5)¶ 0.18
AD/no AD at follow up (% AD) 0/9 (0) 1/8 (13) 6/5 (55)† 0.003
CD/no CD at follow up (% CD) 0/6 (0)§ 2/7 (30) 8/3 (72)† 0.001
Parahippocampal gyrus volume at baseline*
p Value trend
analysisHighest tertile Middle tertile Lowest tertile
(B) Baseline and follow up data according to parahippocampal gyrus volume at baseline:
Number 12 10 8
Baseline data
Age (y) 64.2 (10.4) 64.2 (9.3) 66.1 (10.0) 0.69
MMSE score 27.0 (2.0) 28.2 (1.9) 27.8 (1.7) 0.31
Delayed recall (z score) −0.93 (0.92)‡ −0.80 (0.93) −1.05 (0.76) 0.80
Follow up data
Change MMSE −0.86 (2.3)** −1.1 (3.1) −4.6 (4.5)† 0.05
Change delayed recall 0.61 (1.3)** −0.11 (1.2)† −0.64 (1.4)‡ 0.09
AD/no AD at follow up (% AD) 2/10 (17) 2/8 (20) 3/4 (43)† 0.24
CD/no CD at follow up (% CD) 2/7 (22)§ 3/7 (30) 5/2 (71)† 0.05
MTA score at baseline*
p Value trend
analysisHighest tertile Middle tertile Lowest tertile
(C) Baseline and follow up data according to MTA score at baseline:
Number 12 6 13
Baseline data
Age (y) 59.2 (8.1) 67.9 (2.0) 68.8 (10.1) 0.01
MMSE score 28.3 (1.4) 27.8 (1.9) 27.0 (2.0) 0.08
Delayed recall (z score) −0.86 (0.72)† −0.58 (1.1) −1.1 (0.80)† 0.46
Follow up data
Change MMSE score −0.73 (2.1)† −1.2 (1.6)† −3.9 (5.0)¶ 0.05
Change delayed recall score 0.11 (1.4)§ 0.14 (1.4)† −0.16 (1.3)¶ 0.67
AD/no AD at follow up (% AD) 1/11 (8) 0/6 (0) 6/6 (50)† 0.01
CD/no CD at follow up (% CD) 2/9 (18)† 0/5 (0)† 8/3 (73)‡ 0.01
Values are means (SD). *Tertiles are based on a reference population of healthy subjects. A low tertile score
indicates a small hippocampal or parahippocampal gyrus volume, or an high MTA score; †one patient with
missing data; ‡two patients with missing data; §three patients with missing data; ¶four patients with missing
data; **five patients with missing data.
MMSE, Mini mental state examination; AD, Alzheimer type dementia; CD, cognitive decline: patients with
Alzheimer type dementia at follow up or patients with severe cognitive decline at follow up without dementia.
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The finding that medial temporal lobe atrophy was
associated with cognitive outcome is consistent with earlier
observations of patients with or without mild cognitive
impairment.6–11 All medial temporal lobe measures were found
to improve the predictive accuracy of age and the delayed
recall score for cognitive decline at follow up. These findings
corroborate the finding that assessment of the medial tempo-
ral lobe increases predictive accuracy for clinical outcome
above that of cognitive dysfunction6 10 and are consistent with
the finding that hippocampal volume and memory scores
were independent predictors of Alzheimer type dementia in
patients with minor cognitive impairment.11
The trend analyses and logistic regression analyses indi-
cated that the hippocampal volume was a better predictor of
outcome than the volume of the parahippocampal gyrus. This
corroborates the findings of Kaye et al, who showed that non-
demented patients with Alzheimer type dementia at follow up
had at baseline smaller hippocampal volumes but not
parahippocampal gyrus volumes at baseline than patients
without dementia at follow up,9 but it is by contrast with our
previous study that showed a better predictive accuracy of the
parahippocampal gyrus for Alzheimer type dementia in
non-demented elderly people.10 This discrepancy may have
resulted from the difference in criteria for minor cognitive
impairment that have been used. In our previous study,
patients were selected according to the criteria of minimal
dementia10 and these patients had at baseline more severe
cognitive impairment (average MMSE score of 22.6) than the
patients with mild cognitive impairments in the present study
(average MMSE score 27.7) or the study of Kaye et al (average
MMSE score 26.9).9 Another explanation for the lower
discriminative ability of the parahippocampal gyrus may be
the larger interindividual differences in this structure.36 The
fact that in our previous study the parahippocampal gyrus
volume was nevertheless a better predictor than the hippoc-
ampal volume, was perhaps because measurements were per-
formed on only four slices. This may have decreased the accu-
racy with which the hippocampus was measured because the
shape of the hippocampus changes along the longitudinal
axis. By contrast, the parahippocampal gyrus has amore stable
form. It is therefore possible that the measurement error of
the hippocampus outweighed the interindividual variability of
the parahippocampal gyrus. The hippocampal volume was a
better predictor of Alzheimer type dementia and cognitive
decline in the trend analyses than the MTA score. In the mul-
tivariate analyses, the hippocampal volume and theMTA score
could predict Alzheimer type dementia with the same
accuracy but the hippocampal volumewas a better predictor of
cognitive decline than the MTA score. These findings suggest
that volumetry of the hippocampus should be preferred above
the MTA score in predicting cognitive outcome. However, vol-
umetry of the hippocampus takes about 15 minutes and data
for a reference population of normal patients are needed to
correct for differences in intracranial volume. This will
probably limit the use of volumetry in a clinical setting. The
MTA score has the advantage that it can be scored on hard
copies and that it takes only a few minutes to perform.
Because the MTA score has a good predictive accuracy, it could
be used in settings where volumetry is not possible. One pos-
sible disadvantage of the MTA score is the interrater variabil-
ity. In a previous study it was shown that the interrater agree-
ment on MTA ratings of 100 scans of four raters was fair to
substantial (κ between 0.34 and 0.57), which indicates that
the generalisation of the MTA score may be less satisfactory.34
To prevent interrater variability in MTA scoring raters should
therefore be well trained.
The differences in predictive accuracy between the three
measures of medial temporal lobe atrophy suggest that these
measures assess different aspects of medial temporal lobe
atrophy. To investigate this possibility we correlated in the
present sample post hoc the z scores of the three medial tem-
poral lobe measures with each other. The correlation
coefficient between the volumes of the hippocampus and the
parahippocampal gyrus was 0.69 (p<0.001), the correlation
coefficient between the volume of the hippocampus and the
MTA score was 0.29 (p=0.11), and the correlation coefficient
between the volume of the parahippocampal gyrus and the
MTA score was 0.26 (p=0.17). Because the patients in these
correlations were their own controls, we repeated the correla-
tions using brain volumes and MTA scores that were not cor-
rected for age. Without age correction, the correlation
coefficient between the volumes of the hippocampus and the
parahippocampal gyrus remained the same but the correlation
coefficients between the volumetric measures and the MTA
score were higher (r=0.42, p=0.02 for both the correlation
between the volume of the hippocampus and the MTA score
and the correlation between the volume of the parahippocam-
pal gyrus and the MTA score). The correlation coefficient
between the volume of the hippocampus and the MTA score
was similar to that reported in a previous study.37 These data
indicate that the three measures of medial temporal lobe atro-
phy indeed assess different aspects of medial temporal lobe
atrophy. One possible explanation of the moderate correlation
between the MTA score and the volumetric measures is that
Table 3 Logistic regression analyses of clinical outcome
Change in
deviance*
p Value change
deviance
Overall
accuracy (%)†
Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPV
(%)
AD as outcome:
Step 1 Age 3.2 0.07 78 0 100 – 78
Step 2 Delayed recall 3.2 0.07 74 17 90 33 79
Step 3 HC 5.1 0.02 81 50 90 60 86
Step 3 PHG 1.4 0.25 74 33 86 40 82
Step 3 MTA score 5.5 0.02 81 50 90 60 86
Cognitive decline as outcome:
Step 1 Age 4.6 0.03 71 44 87 67 72
Step 2 Delayed recall 2.6 0.11 71 73 67 60 79
Step 3 HC 24.6 <0.001 100 100 100 100 100
Step 3 PHG 5.2 0.02 75 56 87 71 76
Step 3 MTA score 5.4 0.02 83 78 87 78 87
*Change in deviance is the change in deviance from maximum deviance (step 1) or the previous step (steps
2 and 3); †the overall accuracy, sensitivity, specificity, PPV and NPV were calculated on the basis of the
predicted probability of outcome: Alzheimer type dementia or cognitive decline were considered to be
predicted by the model if the predicted probability of Alzheimer type dementia or cognitive decline was
>0.5.
HC, hippocampus; PHG, parahippocampal gyrus; MTA, medial temporal lobe atrophy; PPV, positive
predictive value; NPV, negative predictive value; –,could not be calculated because no patients were
predicted to have Alzheimer type dementia at follow up.
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the MTA score is based not only on a visual estimation of the
volume of the medial temporal lobe, but also of the volume of
the surrounding CSF spaces, in particular the temporal horn
of the lateral ventricle and the choroid fissure. Evidence for
this explanation comes from the finding that the MTA score
correlated significantly with the volume of the temporal horn
of the lateral ventricle in the present sample (r=0.51,
p=0.003, if both measures were corrected for age, and r=0.69,
p<0.001, if both measures were not corrected for age).
Minor cognitive impairment in the present study was
defined as cognitive impairment that led to a referral to a
memory clinic but that was not severe enough to meet the cri-
teria of dementia which equals GDS stages 2 and 3. There are
also other concepts of minor cognitive impairment, such as
mild cognitive impairment (MCI).38 In the present study, 19
patients met the criteria of MCI (two patients did not meet the
criteria because cognitive test data were missing and 10
patients because they were younger than 60 years). Trend
analyses and logistic regression analyses with these patients
yielded similar results as the analyses with the whole sample
which indicates that the present findings will also apply in
patients with MCI. The mean age in the study sample (65
years) was lower than that of other studies investigating the
predictive accuracy of medial temporal lobe atrophy (mean
age range from 71 to 78).6 10 11 This may have negatively influ-
enced the positive predictive value of medial temporal lobe
atrophy because the conversion rate to dementia is lower in
younger patients than it is in older patients. We corrected for
this difference in conversion rate by including age in the mul-
tivariate models. We also performed analyses with a subgroup
of patients older than 60 years (average 71 years) (data not
shown) which yielded similar results as those with the whole
sample. We did not exclude patients with mild to moderate
depression because mild to moderate depression is often seen
in patients with preclinical Alzheimer type dementia.16
Because depression may cause cognitive impairment we may
have misclassified depressed patients as having cognitive
decline at follow up. This seems unlikely because patients with
cognitive decline at follow up who had high depression scores
at baseline (HDRS score of 19 and 21) had improvement of the
depression scores at follow up (average improvement of five
points). In addition, trend and logistic regression analyses
with correction for depression severity yielded similar results
as the analyses without correction. We included patients with
cardiovascular risk factors or vascular disorders that might
have contributed to cognitive impairment or to conversion to
dementia. However, adjustment for these risk factors or
vascular disorders had no effect on the results (data not
shown). Also exclusion of the patients with a history of a
transient ischaemic attack or a lacunar infarction yielded
similar results.
One of the limitations of the study was the short follow up
period. We may therefore have missed patients who would
have become demented after the follow up assessment. For
this reason we also used a broader definition of cognitive
decline as an outcome measure, but it remains to be
investigated whether the patients with cognitive decline at
follow up who were not demented have since developed
Alzheimer type dementia. Pathological confirmation of the
clinical diagnosis at follow up was not possible and the patho-
logical diagnosis remains therefore uncertain. The small sam-
ple size may have limited the ability to detect significant
differences. The hippocampal volume and parahippocampal
gyrus volumetry and MTA scoring were measured on MRI
with a different scan axis. Because the slice thickness was thin
it seems unlikely that the difference in scan axis has
introduced major bias.We have investigated whether assess-
ment of the medial temporal lobe could increase the predictive
accuracy of age and delayed recall for clinical outcome but it
remains to be investigated which will be the simplest model
for predicting outcome.
The clinical relevance of these findings is that the ability to
detect patients with minor cognitive impairment who are at
high risk for Alzheimer type dementia will increase when data
on age and memory function are combined with measures of
medial temporal lobe atrophy. Assessment of medial temporal
lobe atrophy may therefore be a useful supplement to the
diagnostic investigation of patients with minor cognitive
impairment.
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